1. Home
  2. ALTI vs AURA Comparison

ALTI vs AURA Comparison

Compare ALTI & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$4.32

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.64

Market Cap

318.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTI
AURA
Founded
2020
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.0M
318.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ALTI
AURA
Price
$4.32
$5.64
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.20
AVG Volume (30 Days)
159.7K
197.7K
Earning Date
03-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$226,717,000.00
N/A
Revenue This Year
$19.78
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$4.35
52 Week High
$5.45
$8.27

Technical Indicators

Market Signals
Indicator
ALTI
AURA
Relative Strength Index (RSI) 48.54 54.59
Support Level $3.95 $4.73
Resistance Level $4.45 $5.84
Average True Range (ATR) 0.35 0.30
MACD -0.01 0.08
Stochastic Oscillator 36.59 85.07

Price Performance

Historical Comparison
ALTI
AURA

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: